Drugs Made In America Acquisition Corp. Units (DMAAU) — Capital Reinvestment Ratio

Latest as of September 2025: 0.00x

Drugs Made In America Acquisition Corp. Units (DMAAU) has a Capital Reinvestment Ratio of 0.00x as of September 2025, meaning it reinvests 0% of its operating cash flow ($137.91K) in capital expenditures ($4.00). Check DMAAU goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.00x

Capex / Operating Cash Flow

Operating Cash Flow

$137.91K

USD

Capital Expenditures

$4.00

USD

Data as of

Sep 2025

Most recent filing

Annual Capital Reinvestment Ratio for Drugs Made In America Acquisition Corp. Units (None–None)

Year-by-year Capital Reinvestment Ratio for Drugs Made In America Acquisition Corp. Units from None to None. See Drugs Made In America Acquisition Corp. free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow